November 30th 2024
Insufficient ferric carboxymaltose dosing and timing fail to significantly improve hemoglobin levels, suggesting gaps in perioperative anemia management.
October 27th 2024
New late-breaking ACG 2024 data supports AIMS65 as a risk factor tool for patients undergoing anticoagulant reversal.
October 25th 2024
On October 25, 2024, Kind Pharmaceutical announced receipt of FDA Orphan Drug Designation for AND017 in the treatment of sickle cell disease.
October 14th 2024
Anemia could be a reliable sign of all-cause mortality in patients with heart failure.
A systematic review found cognitive impairment a defining characteristic of SCA, with a notable impact on individuals of all ages.